Table 1.
Inclusion criteria for the trials in the meta-analysis.
Figure 1.
Flow diagram for the selection of the trials.
Table 2.
Characteristics of the included trials.
Figure 2.
The change in lumbar spine bone mineral density (BMD) with the combined interventions of antiresorptive agents and exercise in all of the included studies.
The dotted line represents the mean treatment effect. The diamond denotes the overall treatment effects with 95% confidence intervals (CIs). SMD denotes the standardized mean difference.
Figure 3.
The change in femoral neck bone mineral density (BMD) with the combined interventions of antiresorptive agents and exercise in all of the included studies.
The dotted line represents the mean treatment effect. The diamond denotes the overall treatment effects with 95% confidence intervals (CIs). SMD denotes the standardized mean difference.
Table 3.
Primary and subgroup analyses.